Ann: Science Series CHECKvacc, page-74

Is that true Thaliat? I have seen you say this before re @Davisite. This poster has always been polite & honest to me & in fact helpful at times, sharing an article he thought I’d be interested in on a stock he didn’t hold, or sharing knowledge re labs etc. I can’t comment further really, just my experience on what I am invested in. Maybe before becoming a BOD member if it is the same person?

What a few RAC posters do here on IMU is not DT’s fault & I don’t believe he would be involved in instigating or condoning any of this behaviour. It will only hurt RAC as well. DT comes across as a Professional & decent person, very knowledgeable. There are some really nice guys on RAC board that I respect knowing them from other stocks. It’s not a reflection as a whole on RAC investors or the company. So it’s a bit sad to see this going on.

I don’t understand why some feel the need to come here with their negativity, if everything is so hunky dory over there.

I find it odd & very defensive kind of behaviour from a few, when it’s so unnecessary & very unprofessional.

What gets posted here I believe is fair game for retaliation, but don’t stoop low & do the same over there.

A few rotten apples doesn’t mean the whole basket is spoilt. I note a few trolls here are also posting there now as well, just to stir the pot. I suggest that people look at posting history before passing judgement, because some are not appreciated or welcome on either ‘home turf’.

@Kluck made a very good comment this morning, that Cancer is basically our competition, not different ASX stocks.

Maybe I am naive to some goings on, & not invested in RAC or defending anyone doing things I think are wrong, I have some on ignore because I’m not wasting my time arguing with people who have a clear agenda. Pointless.

IMU’s progress & multiple Big Pharma collaborations speak for themselves. Our ongoing pipeline, platforms & biomarker development will be what is telling, not some opinion rehashed from preliminary data from Her-Vaxx 1/2b when we have progressed so far since the last attack on IMU data. Still waiting on OS & final trial data, 5 years later on Her-Vaxx in Stage 4 Her positive GEJ.

GLTAH